Skip to main content
. 2018 Jun 25;218(Suppl 5):S672–S678. doi: 10.1093/infdis/jiy304

Table 3.

Detection of Synergy in Blocking Cell Entry of Ebola Virus–Like Particles

Drug 1 Top Concentration, μM Drug 2 Top Concentration, μM Log Synergy Volumea Experiments, No.b
Apilimod 0.1 Bepridil 10 11.98 2
Sertraline 10 Toremifene 5 6.57 2
Apilimod 0.1 Toremifene 5 6.00 2
Bepridil 10 Toremifene 5 3.58 2
Clomiphene 5 Clomiphenec 5 0.63 3

Four drug combinations were tested for ability to block Ebola virus–like particle entry, and synergistic effects were determined using MacSynergy software, as described in the Supplementary Methods.

aMacSynergy scores are given at the 99.9% confidence interval. Log synergy volume is averaged over the number of experiments.

bTwo or 3 plates were analyzed in each experiment.

cThe self-cross pair clomiphene/clomiphene was used as an expected negative control.

HHS Vulnerability Disclosure